Cargando…
Adeno-associated virus-mediated brain delivery of 5-lipoxygenase modulates the AD-like phenotype of APP mice
BACKGROUND: The 5-lipoxygenase (5LO) enzymatic pathway is widely distributed within the central nervous system. Previous works showed that this protein is up-regulated in Alzheimer's disease (AD), and that its genetic absence results in a reduction of Amyloid beta (Aβ) levels in the Tg2576 mice...
Autores principales: | Chu, Jin, Giannopoulos, Phillip F, Ceballos-Diaz, Carolina, Golde, Todd E, Pratico, Domenico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277480/ https://www.ncbi.nlm.nih.gov/pubmed/22222029 http://dx.doi.org/10.1186/1750-1326-7-1 |
Ejemplares similares
-
The direct role of 5-lipoxygenase on tau pathology, synaptic integrity and cognition in a mouse model of tauopathy
por: Vagnozzi, Alana N., et al.
Publicado: (2017) -
Brain 5‐lipoxygenase over‐expression worsens memory, synaptic integrity, and tau pathology in the P301S mice
por: Vagnozzi, Alana N., et al.
Publicado: (2017) -
Involvement of 5-lipoxygenase activating protein in the amyloidotic phenotype of an Alzheimer’s disease mouse model
por: Chu, Jin, et al.
Publicado: (2012) -
The 5-lipoxygenase pathway: oxidative and inflammatory contributions to the Alzheimer’s disease phenotype
por: Joshi, Yash B., et al.
Publicado: (2015) -
Gene Knockout of 5-Lipoxygenase Rescues Synaptic Dysfunction and Improves Memory in the Triple-Transgenic Model of Alzheimer’s Disease
por: Giannopoulos, Phillip F., et al.
Publicado: (2013)